journal article·2024-07

A DNA origami device spatially controls CD95 signalling to induce immune tolerance in rheumatoid arthritis

Ling Li, Jue Yin, Wen Ma, Longguang Tang, Jianhua Zou, Linzi Yang, Ting Du, Yi Zhao, Lianhui Wang, Zhen Yang, Chunhai Fan, Jie Chao, Xiaoyuan Chen

Nature Materials· Volume 23· Issue 7
Publisher page

Abstract

DNA origami is capable of spatially organizing molecules into sophisticated geometric patterns with nanometric precision. Here we describe a reconfigurable, two-dimensional DNA origami with geometrically patterned CD95 ligands that regulates immune cell signalling to alleviate rheumatoid arthritis. In response to pH changes, the device reversibly transforms from a closed to an open configuration, displaying a hexagonal pattern of CD95 ligands with ~10 nm intermolecular spacing, precisely mirroring the spatial arrangement of CD95 receptor clusters on the surface of immune cells. In a collagen-induced arthritis mouse model, DNA origami elicits robust and selective activation of CD95 death-inducing signalling in activated immune cells located in inflamed synovial tissues. Such localized immune tolerance ameliorates joint damage with no noticeable side effects. This device allows for the precise spatial control of cellular signalling, expanding our understanding of ligand-receptor interactions and is a promising platform for the development of pharmacological interventions targeting these interactions.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Vital, E. M. & Emery, P. The development of targeted therapies in rheumatoid arthritis. J. Autoimmun. 31, 219–227 (2008).10.1016/j.jaut.2008.04.006 ↗
2. Smolen, J. S. & Aletaha, D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat. Rev. Rheumatol. 11, 276–289 (2015).10.1038/nrrheum.2015.8 ↗
3. Ju, S.-T. et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444–448 (1995).10.1038/373444a0 ↗
4. Vanamee, É. S. & Faustman, D. L. Structural principles of tumor necrosis factor superfamily signaling. Sci. Signal. 11, eaao4910 (2018).10.1126/scisignal.aao4910 ↗
5. Scott, F. L. et al. The Fas–FADD death domain complex structure unravels signalling by receptor clustering. Nature 457, 1019–1022 (2009).10.1038/nature07606 ↗
6. Wang, L. et al. The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol. 17, 1324–1329 (2010).10.1038/nsmb.1920 ↗
7. Balta, G. S. G. et al. 3D cellular architecture modulates tyrosine kinase activity, thereby switching CD95-mediated apoptosis to survival. Cell Rep. 29, 2295–2306 (2019).10.1016/j.celrep.2019.10.054 ↗
8. Rothemund, P. W. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297–302 (2006).10.1038/nature04586 ↗
9. Chandrasekaran, A. R., Anderson, N., Kizer, M., Halvorsen, K. & Wang, X. Beyond the fold: emerging biological applications of DNA origami. ChemBioChem 17, 1081–1089 (2016).10.1002/cbic.201600038 ↗
10. Shaw, A. et al. Spatial control of membrane receptor function using ligand nanocalipers. Nat. Methods 11, 841–846 (2014).10.1038/nmeth.3025 ↗
11. Kwon, P. S. et al. Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition. Nat. Chem. 12, 26–35 (2020).10.1038/s41557-019-0369-8 ↗
12. Wang, Y., Baars, I., Fordos, F. & Hogberg, B. Clustering of death receptor for apoptosis using nanoscale patterns of peptides. ACS Nano 15, 9614–9626 (2021).10.1021/acsnano.0c10104 ↗
13. Comberlato, A., Koga, M. M., Nüssing, S., Parish, I. A. & Bastings, M. M. C. Spatially controlled activation of Toll-like receptor 9 with DNA-based nanomaterials. Nano Lett. 22, 2506–2513 (2022).10.1021/acs.nanolett.2c00275 ↗
14. Fang, T. et al. Spatial regulation of T-cell signaling by programmed death-ligand 1 on wireframe DNA origami flat sheets. ACS Nano 15, 3441–3452 (2021).10.1021/acsnano.0c10632 ↗
15. Shaw, A. et al. Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies. Nat. Nanotechnol. 14, 184–190 (2019).10.1038/s41565-018-0336-3 ↗
16. Wickham, S. F. J. et al. Complex multicomponent patterns rendered on a 3D DNA-barrel pegboard. Nat. Commun. 11, 5768 (2020).
17. Eklund, A. S., Comberlato, A., Parish, I. A., Jungmann, R. & Bastings, M. M. C. Quantification of strand accessibility in biostable DNA origami with single-staple resolution. ACS Nano 15, 17668–17677 (2021).10.1021/acsnano.1c05540 ↗
18. Goldie, I. & Nachemson, A. Synovial pH in rheumatoid knee-joints. I. The effect of synovectomy. Acta Orthop. Scand. 40, 634–641 (1969).10.3109/17453676908989529 ↗
19. Stevens, C. R., Williams, R. B., Farrell, A. J. & Blake, D. R. Hypoxia and inflammatory synovitis: observations and speculation. Ann. Rheum. Dis. 50, 124–132 (1991).10.1136/ard.50.2.124 ↗
20. Farr, M., Garvey, K., Bold, A. M., Kendall, M. J. & Bacon, P. A. Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. Clin. Exp. Rheumatol. 3, 99–104 (1985).
21. Roskams, T., Libbrecht, L., Van Damme, B. & Desmet, V. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells? J. Pathol. 191, 150–153 (2000).10.1002/(SICI)1096-9896(200006)191:2<150::AID-PATH612>3.0.CO;2-I ↗
22. Li, S. et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat. Biotechnol. 36, 258–264 (2018).10.1038/nbt.4071 ↗
23. Liu, S. et al. A DNA nanodevice-based vaccine for cancer immunotherapy. Nat. Mater. 20, 421–430 (2021).10.1038/s41563-020-0793-6 ↗
24. Manuguri, S., Nguyen, M. K., Loo, J., Natarajan, A. K. & Kuzyk, A. Advancing the utility of DNA origami technique through enhanced stability of DNA-origami-based assemblies. Bioconjug. Chem. 34, 6–17 (2023).10.1021/acs.bioconjchem.2c00311 ↗
25. Wang, P. F., Meyer, T. A., Pan, V., Dutta, P. K. & Ke, Y. G. The beauty and utility of DNA origami. Chem 2, 359–382 (2017).10.1016/j.chempr.2017.02.009 ↗
26. Hahn, J., Wickham, S. F. J., Shih, W. M. & Perrault, S. D. Addressing the instability of DNA nanostructures in tissue culture. ACS Nano 8, 8765–8775 (2014).10.1021/nn503513p ↗
27. Ponnuswamy, N. et al. Oligolysine-based coating protects DNA nanostructures from low-salt denaturation and nuclease degradation. Nat. Commun. 8, 15654 (2017).10.1038/ncomms15654 ↗
28. Perrault, S. D. & Shih, W. M. Virus-inspired membrane encapsulation of DNA nanostructures to achieve in vivo stability. ACS Nano 8, 5132–5140 (2014).10.1021/nn5011914 ↗
29. Mei, Q. A. et al. Stability of DNA origami nanoarrays in cell lysate. Nano Lett. 11, 1477–1482 (2011).10.1021/nl1040836 ↗
30. Chandrasekaran, A. R. Nuclease resistance of DNA nanostructures. Nat. Rev. Chem. 5, 225–239 (2021).10.1038/s41570-021-00251-y ↗
31. Schneider, P. et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205–1213 (1998).10.1084/jem.187.8.1205 ↗
32. Algeciras-Schimnich, A. et al. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22, 207–220 (2002).10.1128/MCB.22.1.207-220.2002 ↗
33. Lee, K. H. et al. The role of receptor internalization in CD95 signaling. EMBO J. 25, 1009–1023 (2006).10.1038/sj.emboj.7601016 ↗
34. Malyala, P. & Singh, M. Endotoxin limits in formulations for preclinical research. J. Pharm. Sci. 97, 2041–2044 (2008).10.1002/jps.21152 ↗
35. Hong, E. et al. Structure and composition define immunorecognition of nucleic acid nanoparticles. Nano Lett. 18, 4309–4321 (2018).10.1021/acs.nanolett.8b01283 ↗
36. Namekawa, T., Wagner, U. G., Goronzy, J. J. & Weyand, C. M. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum. 41, 2108–2116 (1998).10.1002/1529-0131(199812)41:12<2108::AID-ART5>3.0.CO;2-Q ↗
37. Gizinski, A. M. & Fox, D. A. T cell subsets and their role in the pathogenesis of rheumatic disease. Curr. Opin. Rheumatol. 26, 204–210 (2014).10.1097/BOR.0000000000000036 ↗
38. Reparon-Schuijt, C. C. et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum. 44, 41–47 (2001).10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0 ↗
39. Okamoto, K. et al. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther. 5, 331–338 (1998).10.1038/sj.gt.3300597 ↗
40. Zhang, H. et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Investig. 100, 1951–1957 (1997).10.1172/JCI119726 ↗
41. Choy, E. H. & Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907–916 (2001).10.1056/NEJM200103223441207 ↗
42. Smolen, J. S. & Steiner, G. Therapeutic strategies for rheumatoid arthritis. Nat. Rev. Drug Discov. 2, 473–488 (2003).10.1038/nrd1109 ↗
43. Fullerton, J. N., O’Brien, A. J. & Gilroy, D. W. Pathways mediating resolution of inflammation: when enough is too much. J. Pathol. 231, 8–20 (2013).10.1002/path.4232 ↗
44. Elliott, M. R., Koster, K. M. & Murphy, P. S. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J. Immunol. 198, 1387–1394 (2017).10.4049/jimmunol.1601520 ↗
45. Achkar, I. W. et al. Oncogenic role of dysregulated leptin signaling in the pathogenesis of ovarian cancer. Transl. Med. Commun. 4, 1 (2019).10.1186/s41231-018-0031-2 ↗
46. Akhtar, S. et al. Cytokine-mediated dysregulation of signaling pathways in the pathogenesis of multiple myeloma. Int. J. Mol. Sci. 21, 5002 (2020).10.3390/ijms21145002 ↗
47. Mehta, M. et al. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology 28, 795–817 (2020).10.1007/s10787-020-00698-3 ↗
48. Brand, D. D., Latham, K. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 2, 1269–1275 (2007).10.1038/nprot.2007.173 ↗
49. Zhou, B. et al. Therapeutic effects of a novel BAFF blocker on arthritis. Signal Transduct. Target. Ther. 4, 19 (2019).10.1038/s41392-019-0051-z ↗
50. Wang, H. et al. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat. Immunol. 2, 632–637 (2001).10.1038/89782 ↗
51. Li, L. A DNA origami device spatially controls CD95 signalling to induce immune tolerance in rheumatoid arthritis. figshare https://doi.org/10.6084/m9.figshare.25111502.v2 (2024).10.6084/m9.figshare.25111502.v2 ↗